Multi-Characteristic Opsin Therapy to Functionalize Retina, Attenuate Retinal Degeneration, and Restore Vision in Mouse Models of Retinitis Pigmentosa
Open Access
- 1 October 2024
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 13 (10) , 25
Abstract
Purpose: Retinal degeneration 1 and 10 (rd1 and rd10) mice are useful animal models of retinitis pigmentosa (RP) with rapidly and slowly progressive pathologies, respectively. Our study aims were to determine the effect of adeno-associated viral vector 2 (AAV2)-delivered multi-characteristic opsin (MCO-010; under the control of a metabotropic glutamate receptor-6 promoter enhancer) on the morphological and functional characteristics of vision in both rd1 and rd10 mice. Methods: Various retinal measures of MCO-010 transduction and electrophysiological, behavioral, and other routine blood analyses were performed in the rd1 and/or rd10 mice after intravitreal injection of 1 µL of MCO-010 or AAV2 vehicle. Functional tests included electroretinogram, visually evoked potential, and behavior assay (optomotor and water maze). Retinal thickness, intraocular pressure, and plasma cytokine levels were also determined. Results: Following intravitreal MCO-010 injection, approximately 80% of bipolar cells were transduced in the retina, and no alterations in retinal thickness were observed at 4 months post-injection. However, retinal thickness significantly decreased in control mice. MCO-010 treatment increased head movements and induced faster navigation of mice to the platform in a water-maze test. The MCO-010 gene therapy helped preserve visually evoked electrical response in the retina and visual cortex. No ocular toxicity, immunotoxicity, or phototoxicity was observed in the MCO-010–treated mice, even under chronic intense light conditions. Conclusions: Intravitreal MCO-010 was well tolerated in rd1 and rd10 mice models of RP, and it appeared to attenuate retinal photoreceptor degeneration based on retinal structure and functional outcome measures. Translational Relevance: As reported here, optogenetic treatment of the inner retina attenuates further retinal degeneration in addition to photosensitizing higher order neurons, and this disease-modifying aspect should be evaluated in optogenetic clinical trials.Keywords
This publication has 45 references indexed in Scilit:
- Safety of intravitreally delivered AAV2 vector‐mediated multi‐characteristic opsin genetic construct in wild type beagle dogsThe Journal of Gene Medicine, 2024
- Emerging Issues in AAV-Mediated In Vivo Gene TherapyMolecular Therapy - Methods & Clinical Development, 2018
- Complexity of retinal cone bipolar cellsProgress in Retinal and Eye Research, 2010
- Age-related decrease in rod bipolar cell density of the human retina: an immunohistochemical studyJournal of Biosciences, 2007
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: A morphological and ERG studyJournal of Comparative Neurology, 2006
- Retinitis pigmentosaThe Lancet, 2006
- Ribbon synapses of the retinaCell and tissue research, 2006
- Retinal degeneration mutants in the mouseVision Research, 2002
- Rate of Visual Field Loss in Retinitis PigmentosaOphthalmology, 1997